GlassScriptPhysician profile
Bernadette Wang Ashraf
NPI 1417084021
$14,333.55
in general payments reported to CMS, 2019-2025
12 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,624 · 2020: $1,202 · 2021: $2,197 · 2022: $2,212 · 2023: $2,434 · 2024: $2,370 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,098.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $10,165.45 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 4 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Allergan, INC. | $1,181.39 | 2019-2022 | |
| Abbvie INC. | $1,069.77 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Integra Lifesciences Corporation | $944.49 | 2020-2022 | |
| Galderma Laboratories, L.P. | $633.55 | 2019-2023 | |
| Tela Bio, INC. | $104.83 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $83.07 | 2025 | |
| Acera Surgical, INC. | $48.97 | 2023-2024 | Restrata Wound Matrix |
| Sientra, INC. | $46.66 | 2022 | |
| Merz North America, INC. | $19.64 | 2019 | |
| Kci USA, INC. | $18.97 | 2023 | Prevena Restor Bellaform |
| Pacira Pharmaceuticals Incorporated | $16.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernadette Wang Ashraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.